Cargando…
1346. The Tetrazole VT-1598 Is Efficacious in a Murine Model of Invasive Aspergillosis with a PK/PD Expected of a Mold-Active CYP51 Inhibitor
BACKGROUND: VT-1598 is a novel fungal CYP51 inhibitor with potent in vitro activity against yeast, mold, and endemic pathogenic fungi (Wiederhold, JAC, 2017). Its tetrazole-based rational drug design imparts much greater selectivity vs. human CYPs (Yates, BMCL, 2017), which could reduce human CYP-re...
Autores principales: | Garvey, Edward P, Sharp, Andrew, Warn, Peter, Yates, Christopher M, Schotzinger, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254293/ http://dx.doi.org/10.1093/ofid/ofy210.1177 |
Ejemplares similares
-
VT-1598 Inhibits the in vitro Growth of Mucosal Candida Isolates and Protects Against Oropharyngeal Candidiasis in IL-17 Deficient Mice
por: Break, Timothy J, et al.
Publicado: (2017) -
VT-1161—A Tetrazole for Management of Mono- and Dual-Species Biofilms
por: Maione, Angela, et al.
Publicado: (2023) -
Biological Warfare at the 1346 Siege of Caffa
por: Wheelis, Mark
Publicado: (2002) -
COLLABORATION AGREEMENT No. K 1598
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2008) -
A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis
por: Brand, Stephen R, et al.
Publicado: (2020)